◆ 会议时间：2023年5月11-14日
◆ 会议地点：法国 巴黎

◆ 会议简介：

2023年第9届世界多发性骨髓瘤争议大会(COMy 2023)将于2023年5月11-14日在法国巴黎举行。大会的宗旨是提供先进的科学与研究，重点关注该领域的最新进展和改善患者护理，大会将为骨髓瘤领域的世界级领导人提供一个独特的机会，就骨髓瘤领域重大和有争议的问题进行宣辩论，这场发人深省的学术对话将解决当前最具挑战性的临床和治疗问题。会议议题包括：疾病生物学进展；免疫疗法：年轻患者的治疗指南；预后预测；非移植适应症患者的治疗选择；复发治疗；骨髓瘤中的CAR-T细胞；难治性骨髓瘤的选择；如何治疗骨髓瘤的专家意见；正在进行的临床试验和未来的试验；阴燃性骨髓瘤和MGUS；等等。未经许可禁止复制摘录转载本站任何内容-国际医学会议网(lingyuint.com)

The 9th World Congress on Controversies in Multiple Myeloma (COMy)
Dates: May 11-14, 2023
Venue: Pullman Tour Eiffel (Paris, France) + Virtual

摘要征集：

Abstract Submission Deadline: April 6, 2023

点此提交摘要>>>Submit Abstract>>>

Abstracts for the Congress:

• Participants who would like to actively participate in the congress are requested to submit an abstract for review by the Scientific Committee.
• The Committee reserves the right to: 1) select the abstracts relevant to the sessions; 2) decide on the final form of presentation.
• The Committee will accept 2 abstracts for poster display per presenting author.
• The List of Posters will be published in the Final Program and on the congress online platform – all accepted abstracts will be included in the 2023 COMy Congress as e-posters only.

Before you begin, please prepare the following information:

• Title of the abstract
• Family names and initials of all authors
• Details of affiliation of all author(s); institution, city, country
• Contact details of the presenting author (email, tel, fax)

Please note: Abstracts cannot exceed 300 words and cannot include tables and graphs.

About Abstract Submission:
Be sure to make all changes, corrections and proofreading before submitting.
Please note: Once you click Submit, you cannot edit the information you entered.
To make any changes after you have submitted, please contact the Congress Secretariat at comy@cme-congresses.com mentioning your name and abstract confirmation number.

Important:
Prior to submission, please use ‘spell check’ within your abstract WORD document in order to avoid spelling errors.

注册费：

Free registration for the online congress

◆ 参会对象：医生、医院科室主任/副主任、住院医师、医院管理者、医护人员以及从事该领域研究的科学家、研究人员、医药企业代表等等。